Corcept Therapeutics Incorporated (CORT)
NASDAQ·Healthcare·Biotechnology
$46.73
+1.10%
Mkt Cap $4.90B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (22 analysts)
$68.40
Range $30.00 – $100.00
Implied Upside
+46.4%
Consensus $68.40 vs current $46.73